In the BioHarmony Drug Report Database
Telavancin
Vibativ (telavancin) is a small molecule pharmaceutical. Telavancin was first approved as Vibativ on 2009-09-11. It is used to treat bacterial infections, infectious skin diseases, pneumonia, staphylococcal infections, and streptococcal infections in the USA. Vibativ’s patents are valid until 2027-01-01 (FDA).
Trade Name
|
Vibativ |
|---|---|
Common Name
|
telavancin |
ChEMBL ID
|
CHEMBL507870 |
Indication
|
bacterial infections, infectious skin diseases, pneumonia, staphylococcal infections, streptococcal infections |
Drug Class
|
Vancomycin-related compounds |
Image (chem structure or protein)